← Back to Search

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

N/A
Waitlist Available
Led By Dori Beeler
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this research is to understand cancer related fatigue in patients with non-small cell lung cancer (NSCLC), who are being treated with an immune checkpoint inhibitor.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Themes from qualitative interviews with patients
Secondary study objectives
Cancer caregiving tasks, consequences, and needs
Severity and impact of cancer-related fatigue (CRF)
Themes from qualitative interviews with caregivers

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Non-small cell lung cancer (NSCLC)Experimental Treatment1 Intervention
Non-small cell lung cancer (NSCLC) patients treated with with immune checkpoint inhibitor.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Interviews
2017
N/A
~3830

Find a Location

Who is running the clinical trial?

Atrium Health Levine Cancer InstituteOTHER
27 Previous Clinical Trials
3,753 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,295 Total Patients Enrolled
Dori BeelerPrincipal InvestigatorAtrium Health Levine Cancer
~27 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top